Implementing Single Use Technologies in Sterile Vaccines Processing
Implementing Single Use Technologies in Sterile Vaccines Processing
This on-demand webinar presented by Charlotte Masy of GSK is a case study illustration of GSK’s strategic approach for sterility assurance.
One of the main challenges when considering single-use technologies in sterile vaccines manufacturing is to ensure the highest level of assurance of integrity and sterility.
This webinar presented by Charlotte Masy of GSK is a case study illustration of GSK’s strategic approach for sterility assurance.
Topics covered:
- How a Quality by Design (QbD) approach has been applied to develop, design and qualify single-use systems for vaccine manufacturing
- How GSK manage sterility assurance concerns
- Assessing and mitigating risks to integrity of SUS in sterile applications
Speaker
Charlotte Masy
Technical Lifecycle Project Manager
TLCM-MSAT
GlaxoSmithKline
Learn more about the Helium Integrity Test
Manage risk in your critical process with this high sensitivity, supplier integrity test for single-use systems, filling sets and mixer biocontainers
Biotech | Pall Corporation webinar series
Integrity Assurance for Single-Use Systems An End-User’s Perspective
What should you consider when building an integrity control strategy for your single-use systems (SUS)? How do you overcome application challenges?
Join leading industry experts Charlotte Masy of GSK and Patrick Evrard from Pall Corporation to gain insights and answers in this webinar from BioPharma Asia on integrity Assurance for Single-Use Systems, an End-User’s Perspective. They will present several case studies to show how integrity concerns can be practically addressed for cGMP manufacturing applications and the results observed a few years on.
Attendees will learn about:
- The latest regulatory requirements for integrity assurance of SUS
- The different technologies available to control integrity of SUS
- Key parameters that affect integrity measurements
Register now for this webinar from industry experts on October 6.